MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.160
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.200
+0.040 (3.45%)
After-hours: Mar 9, 2026, 6:55 PM EDT
MIRA Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 49 | 19 | 16 | - | - | - |
| Market Cap Growth | 166.65% | 21.65% | - | - | - | - |
| Enterprise Value | 41 | 15 | 10 | - | - | - |
| Last Close Price | 1.16 | 1.14 | 1.05 | - | - | - |
| PB Ratio | 6.07 | 8.58 | 3.55 | - | - | - |
| P/TBV Ratio | 6.43 | 8.58 | 3.55 | - | - | - |
| Debt / Equity Ratio | - | - | 0.00 | -0.82 | 0.13 | -1.32 |
| Net Debt / Equity Ratio | -1.00 | -1.29 | -1.05 | -0.23 | -1.11 | -1.27 |
| Quick Ratio | 89.79 | 3.92 | 8.27 | 0.26 | 2.57 | 0.04 |
| Current Ratio | 90.53 | 3.99 | 8.71 | 0.36 | 2.66 | 0.04 |
| Return on Equity (ROE) | -123.33% | -238.90% | -634.30% | -847.77% | -198.47% | - |
| Return on Assets (ROA) | -74.64% | -127.59% | -184.05% | -209.10% | -79.65% | - |
| Return on Capital Employed (ROCE) | -94.10% | -364.50% | -194.90% | 1376.60% | -95.20% | 298.40% |
| Earnings Yield | -58.50% | -41.59% | -77.21% | - | - | - |
| Buyback Yield / Dilution | -17.53% | -10.91% | 20.73% | -38.60% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.